Efficacy versus safety: the dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease

Por Iannopollo, Gianmarco, Camporotondo, Rita, De Ferrari, Gaetano M, Leonardi, Sergio
Publicado em 2014

Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems

Por Dusi, Veronica, Ghidoni, Alice, Ravera, Alice, De Ferrari, Gaetano M., Calvillo, Laura
Publicado no Mediators Inflamm (2016)

Corrigendum to “Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems”

Por Dusi, Veronica, Ghidoni, Alice, Ravera, Alice, De Ferrari, Gaetano M., Calvillo, Laura
Publicado no Mediators Inflamm (2018)

Editorial: Sudden Cardiac Death and Channelopathies

Por Baltogiannis, Giannis, Conte, Giulio, Sieira, Juan, De Ferrari, Gaetano M., Brugada, Pedro
Publicado no Front Cardiovasc Med (2020)

QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy

Por Sala, Michela, Vicentini, Alessandro, Brambilla, Paolo, Montomoli, Cristina, Jogia, Jigar RS, Caverzasi, Eduardo, Bonzano, Alberto, Piccinelli, Marco, Barale, Francesco, De Ferrari, Gaetano M
Publicado em 2005

Echocardiographic estimation of right ventricular wall tension: haemodynamic comparison and long-term follow-up

Por Annone, Umberto, Bocchino, Pier P., Marra, Walter G., D’Ascenzo, Fabrizio, Magnino, Corrado, Montefusco, Antonio, Omedè, Pierluigi, Veglio, Franco, Milan, Alberto, de Ferrari, Gaetano M.
Publicado no Pulm Circ (2019)

How does the TRS 2°P score relate to real-world patients?

Por Bonaca, Marc P, De Ferrari, Gaetano M, Atar, Dan, Bash, Lori D, Lautsch, Dominik, Bohula, Erin A, Horack, Martin, Brudi, Philippe, Ferrieres, Jean, Gitt, Anselm K
Publicado no Eur Heart J Cardiovasc Pharmacother (2018)

Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Preventi...

Por Kidd, Stephen K., Bonaca, Marc P., Braunwald, Eugene, De Ferrari, Gaetano M., Lewis, Basil S., Merlini, Piera A., Murphy, Sabina A., Scirica, Benjamin M., White, Harvey D., Morrow, David A.
Publicado no J Am Heart Assoc (2016)

Rationale and study design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF

Por De Ferrari, Gaetano M, Tuinenburg, Anton E, Ruble, Stephen, Brugada, Josep, Klein, Helmut, Butter, Christian, Wright, David J, Schubert, Bernd, Solomon, Scott, Meyer, Scott, Stein, Kenneth, Ramuzat, Agnes, Zannad, Faiez
Publicado no Eur J Heart Fail (2014)

Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol: A Prespecified Analysis of the IMPROVE-IT Trial

Por Giugliano, Robert P., Wiviott, Stephen D., Blazing, Michael A., De Ferrari, Gaetano M., Park, Jeong-Gun, Murphy, Sabina A., White, Jennifer A., Tershakovec, Andrew M., Cannon, Christopher P., Braunwald, Eugene
Publicado no JAMA Cardiol (2017)

Torsades de pointes following acute myocardial infarction: Evidence for a deadly link with a common genetic variant

Por Crotti, Lia, Hu, Dan, Barajas-Martinez, Hector, De Ferrari, Gaetano M., Oliva, Antonio, Insolia, Roberto, Pollevick, Guido D., Dagradi, Federica, Guerchicoff, Alejandra, Greco, Federica, Schwartz, Peter J., Viskin, Sami, Antzelevitch, Charles
Publicado em 2012

Contemporary data on treatment practices for low-density lipoprotein cholesterol in 3867 patients who had suffered an acute coronary syndrome across the world

Por Gitt, Anselm K., Lautsch, Dominik, Ferrières, Jean, De Ferrari, Gaetano M., Vyas, Ami, Baxter, Carl A., Bash, Lori D., Ashton, Veronica, Horack, Martin, Almahmeed, Wael, Chiang, Fu-Tien, Poh, Kian Keong, Brudi, Philippe, Ambegaonkar, Baishali
Publicado no Data Brief (2017)

Contemporary data on treatment practices for low-density lipoprotein cholesterol in 6794 patients with stable coronary heart disease across the world

Por Gitt, Anselm K., Lautsch, Dominik, Ferrières, Jean, De Ferrari, Gaetano M., Vyas, Ami, Baxter, Carl A., Bash, Lori D., Ashton, Veronica, Horack, Martin, Almahmeed, Wael, Chiang, Fu-Tien, Poh, Kian Keong, Brudi, Philippe, Ambegaonkar, Baishali
Publicado no Data Brief (2018)

Acute Kidney Injury Definition and In‐Hospital Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST‐Segment Elevation Myocardial Infarction

Por Marenzi, Giancarlo, Cosentino, Nicola, Moltrasio, Marco, Rubino, Mara, Crimi, Gabriele, Buratti, Stefano, Grazi, Marco, Milazzo, Valentina, Somaschini, Alberto, Camporotondo, Rita, Cornara, Stefano, De Metrio, Monica, Bonomi, Alice, Veglia, Fabrizio, De Ferrari, Gaetano M., Bartorelli, Antonio L.
Publicado no J Am Heart Assoc (2016)

Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial

Por Gencer, Baris, Mach, François, Murphy, Sabina A., De Ferrari, Gaetano M., Huber, Kurt, Lewis, Basil S., Ferreira, Jorge, Kurtz, Christopher E., Wang, Huei, Honarpour, Narimon, Keech, Anthony C., Sever, Peter S., Pedersen, Terje R., Sabatine, Marc S., Giugliano, Robert P.
Publicado no JAMA Cardiol (2020)

Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients

Por De Ferrari, Gaetano M, Fox, Keith AA, White, Jennifer A, Giugliano, Robert P, Tricoci, Pierluigi, Reynolds, Harmony R, Hochman, Judith S, Gibson, C Michael, Théroux, Pierre, Harrington, Robert A, Van de Werf, Frans, White, Harvey D, Califf, Robert M, Newby, L Kristin
Publicado em 2014

Effect of Evolocumab on Type and Size of Subsequent Myocardial Infarction: A Prespecified Analysis of the FOURIER Randomized Clinical Trial

Por Wiviott, Stephen D., Giugliano, Robert P., Morrow, David A., De Ferrari, Gaetano M., Lewis, Basil S., Huber, Kurt, Kuder, Julia F., Murphy, Sabina A., Forni, Danielle M., Kurtz, Christopher E., Honarpour, Narimon, Keech, Anthony C., Sever, Peter S., Pedersen, Terje R., Sabatine, Marc S.
Publicado no JAMA Cardiol (2020)

Mortality Risk Assessment Using CHA(2)DS(2)-VASc Scores in Patients Hospitalized With Coronavirus Disease 2019 Infection

Por Ruocco, Gaetano, McCullough, Peter A., Tecson, Kristen M., Mancone, Massimo, De Ferrari, Gaetano M., D'Ascenzo, Fabrizio, De Rosa, Francesco G., Paggi, Anita, Forleo, Giovanni, Secco, Gioel G., Pistis, Gianfranco, Monticone, Silvia, Vicenzi, Marco, Rota, Irene, Blasi, Francesco, Pugliese, Francesco, Fedele, Francesco, Palazzuoli, Alberto
Publicado no Am J Cardiol (2020)

Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial

Por Zannad, Faiez, De Ferrari, Gaetano M., Tuinenburg, Anton E., Wright, David, Brugada, Josep, Butter, Christian, Klein, Helmut, Stolen, Craig, Meyer, Scott, Stein, Kenneth M., Ramuzat, Agnes, Schubert, Bernd, Daum, Doug, Neuzil, Petr, Botman, Cornelis, Castel, Maria Angeles, D'Onofrio, Antonio, Solomon, Scott D., Wold, Nicholas, Ruble, Stephen B.
Publicado no Eur Heart J (2015)

Clinical neurocardiology defining the value of neuroscience‐based cardiovascular therapeutics

Por Shivkumar, Kalyanam, Ajijola, Olujimi A., Anand, Inder, Armour, J. Andrew, Chen, Peng‐Sheng, Esler, Murray, De Ferrari, Gaetano M., Fishbein, Michael C., Goldberger, Jeffrey J., Harper, Ronald M., Joyner, Michael J., Khalsa, Sahib S., Kumar, Rajesh, Lane, Richard, Mahajan, Aman, Po, Sunny, Schwartz, Peter J., Somers, Virend K., Valderrabano, Miguel, Vaseghi, Marmar, Zipes, Douglas P.
Publicado no J Physiol (2016)